Furthermore, the supernatant derived from GPX4‐loaded oncolytic vaccinia virus (OVV‐GPX4) can significantly strengthen the function of CD8+ T cells in tumour suppression via decreasing the CD36 expression and reducing lipid peroxidation ex vivo, reinforcing the tumour‐killing effects of immunotherapy in Panc02 mouse model.161. This evidence concerns the gene CD36 and neoplasm.